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Abstract
Background Advanced cancer therapeutics have improved patient survival, leading to an increase in the number of patients who
require long-term outpatient chemotherapy. However, the available schedule options for chemotherapy are generally limited to
traditional business hours.
Method In 2017, we surveyed 721 patients with cancer in Okayama, Japan, regarding their preferences for evening and weekend
(Friday evening, Saturday, and Sunday) chemotherapy appointments.
Results A preference for evening and weekend appointment options was indicated by 37% of the respondents. Patients who
requested weekend chemotherapy were younger, female, with no spouse or partner, living alone, employed, and currently
receiving treatment. Among these factors, age and employment status were significantly associated with a preference for
weekend chemotherapy, according to multivariate analysis.
Conclusion Our findings reveal a demand for evening and weekend outpatient chemotherapy, especially among young,
employed patients.
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Introduction
Advanced cancer therapeutics have improved patient survival
but have also led to an increase in the number of patients who
require long-term outpatient chemotherapy [1–3]. Treatment of
patients with cancer in an outpatient setting is important for re-
ducing the social burden of therapy and for maintaining quality
of life (QoL) among these patients, as it allows them to integrate
treatment into daily life [4–7]. However, outpatient chemothera-
py often involves an extended duration of treatment, frequent
hospital visits, long examinations before treatment, and (in some
instances) prolonged infusion of anticancer drugs [8].
Consequently, outpatient treatment may affect patients’ daily life
[9, 10]. The burdens associated with numerous extended-
duration chemotherapy appointments may be partially mitigated
by accommodating the patients’ lifestyles, such as by offering
evening or weekend outpatient chemotherapy. Most Japanese
hospitals, especially cancer treatment hospitals, offer outpatient
chemotherapy only during weekday business hours.While a few
hospitals currently offer weekend outpatient chemotherapy, the
patient demand for this service has not been formally evaluated.
The aims of this study were (i) to assess whether there is a
substantial demand for evening or weekend outpatient chemo-
therapy and (ii) to identify the sociodemographic and clinical
factors of patients with a preference for evening or weekend
outpatient chemotherapy.
Methods
Okayama Prefecture is a prefecture in Japan with a total popula-
tion of approximately 1.9 million (approximately 1.2 million
reside in two major cities, Okayama and Kurashiki). In a 2017
survey, 29.6% of the population was ≥ 65 years of age.
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Approximately 5600 people in the prefecture die from cancer
each year. Our study was based on the results of a questionnaire
sent to all designated cancer hospitals in Okayama Prefecture.
From August to September 2017, we conducted an anon-
ymous, cross-sectional survey of the patients at 13 designated
cancer hospitals (listed in Acknowledgements) in Okayama
Prefecture, by means of a questionnaire distributed to outpa-
tients ≥ 20 years of age who were currently undergoing treat-
ment for cancer. Survey items included basic demographic
information (i.e., age and sex), social background (i.e., marital
status, cohabitation status, residence, employment, and annual
personal income), and cancer characteristics (i.e., cancer type,
current treatment status, and duration of treatment). Patients
were also queried regarding their desire for evening and week-
end (i.e., Friday evening, Saturday, or Sunday) outpatient che-
motherapy. Personal income was stratified into annual income
of < $20,000, $20,000–$39,999, and ≥ $40,000, according to
the currency conversion rate at the end of the survey (US $1 =
¥112.47, 30 September 2017). The age at diagnosis and dura-
tion of treatment for patients with multiple cancers were de-
fined as the age at diagnosis of the first cancer and the total
duration of all cancer treatments, respectively. After the ques-
tionnaire had been completed by outpatients at each hospital,
it was returned by mail to our hospital.
The interest of the survey respondents in weekend outpatient
chemotherapy was assessed, and the relationships between pa-
tients’ sociodemographic and clinical factors were then analyzed.
Statistical analysis was conducted using SPSS Statistics, version
25.0 (IBM Corp., Armonk, NY, USA). The chi-square test was
used for comparison, with differences considered significant at
p < 0.05. Multivariate logistic regression analysis was performed
using factors identified as significant in univariate analysis. The
study protocol was approved by the Institutional Review Board
of each participating hospital.
Results
The questionnaire was distributed to a total of 1500 patients; of
these, 721 responded (48.1%). A preference for weekend che-
motherapy was indicated by 36.5% of the respondents; the most
common request was a Saturday appointment option (Table 1).
Sociodemographic and clinical characteristics of the pa-
tients and the relationship of each factor with the desire for
weekend chemotherapy are summarized in Tables 2, 3, and 4.
A large number of questionnaire respondents were women,
although men are generally more likely to develop cancer.
The high number of women among the respondents was pre-
sumably because of the high response rates among patients
with breast cancer (25%) and gynecological cancers (7%).
Because these cancer types often affect younger people than
other cancers [11, 12], the women who participated in the
study were 8 years younger than the men who participated
in the study. The average ages of cancer onset were 55 years
for women and 63 years for men (Table 3). This clinical char-
acteristic may have led to bias in the sociodemographic char-
acteristics of patients with cancer in this study [12].
The relationships between a preference for weekend chemo-
therapy and sociodemographic and clinical factors were ana-
lyzed; results are shown in Tables 2 and 4. Patients who were
younger, female, with no spouse/partner, living alone, and
employed most commonly indicated a preference for evening
and weekend chemotherapy. Multivariate analysis showed that
age and employment status were significantly associated with a
preference for weekend chemotherapy (Table 5).
Discussion
To the best of our knowledge, this is the first study to evaluate
interest in evening and weekend outpatient chemotherapy.
Outpatient chemotherapy services are important for mainte-
nance of patient QoL; however, outpatient treatment requires
frequent visits to the hospital, which may be socially burden-
some for some patients with cancer. To reduce the social bur-
den on patients with cancer, we explored whether there was an
unmet demand for evening or weekend chemotherapy.
In our study, nearly 37% of patients expressed interest in
weekend outpatient chemotherapy. Notably, in a study of the
employment and economic burdens posed by cancer treat-
ment, two common social costs of cancer, 21% of Japanese
patients took early retirement due to cancer [13], while 44%
reported a financial burden imposed by cancer treatment [14].
Our data showed that a similar number of patients reported a
burden associatedwith the availability of outpatient anticancer
chemotherapy on weekdays alone.
Possible burdens of outpatient chemotherapy for patients
with cancer include (i) a direct burden to travel to and from the
hospital, such as transportation cost and physical effort, (ii)
social burdens required for hospital visits, such as taking time
off of work, and so on. Several factors, either alone or in
combination, may influence the desire for weekend outpatient
chemotherapy. For example, younger patients might have
more work and a busier social life [15, 16], which would
Table 1 Desire for Friday evening and weekend chemotherapy
N %







increase their interest in weekend treatment. Furthermore,
older patients might experience difficulty in traveling to the
hospital [17] and would therefore also prefer a weekend treat-
ment option. In our study, factors presumably related to the
travel burden, such as proximity to the hospital or reliance on a
spouse or cohabitant for assistance in traveling to the hospital,
were identified in univariate analysis. However, multivariate
analysis found that age and employment status, but not direct
burden to travel, were significantly associated with a desire for
weekend chemotherapy. These results suggested that it was
Table 2 Patient sociodemographic characteristics and results of
univariate analysis
Total Request
Characteristics N (%) No Yes OR p value
Age group at time of study
Less than 40 years 19 (2.6) 8 11
40–59 years 254 (35.2) 109 145
60–79 years 400 (55.5) 300 100
More than 80 years 43 (6) 37 6 82.36 < 0.001
Missing 5 (0.7)
Gender
Male 309 (42.9) 219 90
Female 410 (56.9) 238 172 12.51 < 0.001
Missing 2 (0.3)
Residence status
Living in Okayama 647 (89.7) 413 234
Moved to Okayama 25 (3.5) 12 13
Live in another prefecture 44 (6.1) 29 15 2.72 0.256
Missing 5 (0.7)
Marital status
Spouse/partner 544 (75.5) 361 183
No 175 (24.3) 97 78 6.84 0.009
Missing 2 (0.3)
Living situation
Live alone 53 (7.4) 32 21
One housemate 266 (36.9) 189 77
More than two 384 (53.3) 228 156 9.59 0.008
Missing 18 (2.5)
Working
Yes 524 (72.7) 300 224




Less than $20,000 236 (32.7) 138 98
$20,000–$39,999 192 (26.6) 111 81
More than $40,000 155 (21.5) 87 68 0.22 0.898
Missing 138 (19.1)
At time of study
Less than $20,000 306 (42.4) 180 126
$20,000–$39,999 140 (19.4) 79 61
More than $40,000 100 (13.9) 55 45 0.54 0.763
Missing 175 (24.3)
OR odds ratio
Table 3 Patient clinical characteristics (1)
Characteristics N Mean (SD)
Age at diagnosis
Male 308 63.04 (10.2)
















Table 4 Patient clinical characteristics (2) and results of univariate
analysis
Total Request
Characteristics N (%) No Yes OR p value
Treatment status
Currently receiving 498 (69.1) 328 170
Under inspection 192 (26.6) 109 83
Completed 19 (2.6) 10 9 5.83 0.054
Missing 12 (1.7)
Duration of cancer therapy
Less than 6 months 243 (33.7) 149 94
6 months–1 year 131 (18.2) 81 50
1–2 years 102 (14.1) 67 35
2–3 years 57 (7.9) 33 24
3–5 years 77 (10.7) 51 26
More than 5 years 89 (12.3) 58 31 1.84 0.872
Missing 22 (3.1)
SD standard deviation, OR odds ratio
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difficult for patients with cancer to allocate sufficient time to
visit the hospital, whereas travel itself was a smaller burden.
As a demographic factor, age can be confounded by other
factors, such as the higher likelihood of employment among
younger patients. However, age remained significant in multivar-
iate analysis, even after employment was eliminated as a poten-
tially confounding factor. Although adolescents and young adults
comprise a small percentage of patients with cancer, their med-
ical needs are often unmet [15, 18] and specific types of support
may be required [18, 19]. For example, adolescent and young
adult patients may require greater effort to visit the farther and
more specialized hospital [20, 21]. Younger patients have a larg-
er social role and are thus likely to view outpatient hospital visits
as burdensome, which would explain their interest in a weekend
chemotherapy option.
Employment is also a major social consideration for patients
with cancer [22], and employment itself has been shown to im-
prove their QoL [23, 24]. Since 2012, the Japanese government
has promoted opportunities for patients with cancer to continue
employment or to be re-employed at their jobs, through the Basic
Plan to Promote Cancer Control Program [25]. An equally com-
mon social problem of patients with cancer is income [26, 27],
which is directly related to employment [28, 29]. Thus, the desire
for weekend chemotherapy may have been linked to income.
However, our data suggested that employment itself played a
larger role than income in the desire for weekend chemotherapy.
This might have been due to the importance of employment in
Japan. Takahashi et al. found that, among Japanese patients with
cancer, the main reasons for leaving a job were “I did not want to
be a burden atmyworkplace,” “I anticipated a lack of energy and
physical strength for work,” and “I was not confident that I could
balance cancer treatment and work” [13]. These findings were
presumed to reflect the greater value placed by Japanese patients
with cancer on the impact of their treatment with respect to their
employer and colleagues, rather than the loss of income due to
lack of employment.
The patients in our survey reported that low effort was needed
to visit the hospital. Several reports in other countries found that
the effort needed to visit the hospital, such as the distance that had
to be traveled, affected the prognosis. In Japan, the burden of
visiting the hospital may be less than in other countries because
of free access to the hospital and the relative ease of travel to local
hospitals [21, 30].
Our study was based on an open-ended survey format with
hundreds of respondents across multiple hospitals. However, our
questionnaire-based approach had several limitations; therefore,
our results may not be generalizable to all patients with cancer.
Participants were treated at multiple cancer treatment centers,
which may have confounded the results. Moreover, social factors
are complex, and this survey did not consider all possible trends. It
should also be noted that, despite patient interest in evening and
weekend chemotherapy, adjustments to weekly chemotherapy
availability may require additional medical staff, materials, and
changes in the hospital work environment. While some hospitals
are able to offer evening and weekend chemotherapy, this may
not be feasible for all hospitals, as it would require major changes
in their healthcare systems.However, our survey resultsmay be of
interest to institutions considering alternative treatment schedules.
In summary, the interest of patients with cancer in evening
and weekend outpatient chemotherapy was influenced by age
and employment status. Meeting this medical need may alle-
viate a social burden. Thus, along with efforts to reduce the
physical side effects of chemotherapy, efforts should be
expended to reduce the social burden, such as by providing
evening and weekend outpatient chemotherapy.
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Table 5 Results of logistic regression analysis of relationships between
a desire for weekend outpatient chemotherapy and various factors
OR p value
Age group 0.388 < 0.001
Gender 1.332 0.123
Marital status 0.735 0.161
Living situation 1.11 0.479
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